FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | MENS | CDXS | ||
| Company | FS Development Corp II Cl A | Jyong Biotech Ltd | Codexis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.05 | 2.61 | 2.01 | ||
| High | 10.16 | 2.80 | 2.23 | ||
| Low | 9.69 | 2.55 | 2.01 | ||
| Latest | 9.80 | 2.68 | 2.21 | ||
| Change | -0.20 | +0.15 | +0.23 | ||
| % Change | -2.00% | +5.93% | +11.62% | ||
| Volume | 289,100 | 130,300 | 2,206,200 | ||
| 20-Day Average Volume | 227,795 | 196,110 | 4,213,060 | ||
| Previous Close | 10.00 | 2.53 | 1.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 2.09 | 1.67 | ||
| 20-Day Raw Stochastic | 2.99% | 89.43% | 98.10% | ||
| 20-Day Relative Strength | 38.90 | 47.22 | 70.06 | ||
| Weighted Alpha | -13.88 | -39.65 | +8.37 | ||
| Today's Opinion | 8% Buy | 56% Sell | 24% Buy | ||
| Previous Opinion | 8% Buy | 56% Sell | 8% Buy | ||
| Last Month's Opinion | 72% Buy | 56% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | +24.65% since 03/31/26 | +35.58% since 03/31/26 | ||
| Low | 9.64 on 12/21/21 | 2.13 on 04/01/26 | 1.66 on 04/01/26 | ||
| High | 10.86 on 12/21/21 | 2.80 on 04/08/26 | 2.23 on 04/08/26 | ||
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | +24.07% since 03/06/26 | +79.67% since 03/06/26 | ||
| Low | 9.64 on 12/21/21 | 1.66 on 03/20/26 | 1.15 on 03/09/26 | ||
| High | 15.00 on 12/01/21 | 2.80 on 04/08/26 | 2.23 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | -33.00% since 01/08/26 | +31.55% since 01/08/26 | ||
| Low | 9.64 on 12/21/21 | 1.43 on 02/11/26 | 0.96 on 03/04/26 | ||
| High | 15.05 on 11/19/21 | 4.10 on 01/20/26 | 2.23 on 04/08/26 | ||
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | -94.76% since 10/08/25 | -16.45% since 10/08/25 | ||
| Low | 9.64 on 12/21/21 | 1.43 on 02/11/26 | 0.96 on 03/04/26 | ||
| High | 15.05 on 11/19/21 | 63.00 on 10/23/25 | 2.93 on 10/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 203,755 | 200,821 | ||
| Shares Outstanding, K | 20,727 | 76,028 | 90,869 | ||
| Annual Sales | 0 | 0 | 70,390,000 | ||
| Annual Net Income | 0 | -3,019,000 | -43,970,000 | ||
| Last Quarter Sales | 0 | N/A | 38,920,000 | ||
| Last Quarter Net Income | -1,220,000 | N/A | 9,600,000 | ||
| 60-Month Beta | N/A | N/A | 2.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | N/A | 0.11 on 03/11/26 | ||
| Latest Earnings Date | 01/01/70 | N/A | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||